Kanna for Sleep: Can It Help You Wind Down? (2026)

No — not in the way melatonin or a sedating herb is. Kanna's pharmacology points toward mood and calm rather than sedation. Harvey et al. 2011 (Journal of Ethnopharmacology) describe its dual action: kanna works through a serotonin-reuptake inhibitor and a PDE4 inhibitor at once — which is what sets it apart from kava, CBD, and kratom. That's a mood-and-calm profile, not a knockout one. Kava acts on GABA and leans toward physical relaxation; kanna does not share that mechanism.

So the accurate framing is this: kanna isn't a sleeping pill, but at the calmer end of its range it can help quiet a busy, anxious-feeling evening — and for some people, an evening that feels calmer is an evening that ends in easier sleep. That's an indirect, wind-down role, described experientially, not a claim that kanna treats insomnia.

The most directly relevant data point is modest and we'll report it as such. In Chiu et al. 2014 (Evidence-Based Complementary and Alternative Medicine, n=21, 3 weeks), adults aged 45–65 took 25mg/day of standardized kanna extract. In a 3-week randomized trial, 25mg/day of standardized kanna improved cognitive flexibility versus placebo — and alongside the cognitive findings, participants reported a subjective improvement in sleep quality.

Two honest caveats. First, this was a subjective, self-reported measure, not an objective sleep-lab study with EEG or actigraphy. Second, n=21 over three weeks is small and short. It's a genuine signal worth mentioning — and far from proof that kanna is a sleep treatment. We'd be misrepresenting the literature to call it more than a preliminary, encouraging note.

Kanna behaves differently depending on how much you take. The widely-reported pattern — drawn from traditional use and user experience rather than a controlled dose-ranging trial, so treat it as experiential — is that lower doses tend to feel more uplifting and stimulating, while higher doses tend to feel calmer and more sedating.

That single fact reorganizes how you'd use kanna for the evening. A small, bright daytime dose is the wrong tool near bed; if anything it can be activating and counterproductive. A higher, calm-leaning dose, taken later in the day, is far more likely to fit a wind-down. The same is true of product type: a calm-positioned gummy or capsule is a better evening match than an uplifting, high-mesembrine concentrate or tincture designed to energize.

For the full breakdown of how onset, duration, and the uplift-vs-calm axis play out, see our guide to what kanna actually feels like.

If you want to try kanna in the evening, the logic above points to calm-positioned, standardized products rather than energizing concentrates. A few sensible, widely-available options:

Double Wood Kanna Extract (50mg) — a calm-leaning, standardized capsule (50mg extract, ≥0.4% alkaloids) that sits toward the higher, quieter end of the range. UltraKanna Zen Gumdrops — a 25mg gumdrop from a line explicitly tuned for calm rather than uplift, which makes it an easy evening match. And NOW Calm & Focus — a 25mg Zembrin capsule paired with GABA and positioned toward calm, matching the clinically-studied extract and dose.

By contrast, an uplifting, high-mesembrine concentrate or a tincture marketed for energy is the wrong call near bedtime — those lean stimulating. Whatever you choose, start with a single standardized dose and give it 30–45 minutes; our kanna dosage guide walks through how dosing changes by format. For the overall best-in-class picks, see the best kanna you can buy.

We don't run clinical trials. These picks reflect disclosed alkaloid content, standardization and COA transparency, and a calm-leaning formulation — not our own lab testing or any claim that kanna treats a sleep problem.

The same rule that governs every kanna use applies in the evening. Because kanna raises serotonin much like an SSRI does, it must not be combined with SSRIs, SNRIs, MAOIs, or other serotonergic medications without medical advice. If you take an antidepressant — including ones some people take to help with sleep — ask your prescriber before adding kanna. It's also generally advised to avoid kanna in pregnancy.

For context, not alarm: documented serotonin-syndrome cases from kanna are essentially absent, and a 3-month placebo-controlled trial in 37 adults (Nell et al. 2013) found 8mg and 25mg daily doses were well-tolerated with no significant changes in vitals, ECG, blood chemistry, or weight. The caution is a precaution based on mechanism. Mild, dose-related side effects can include headache, nausea, and occasional drowsiness.

These statements have not been evaluated by the Food and Drug Administration. Kanna is not intended to diagnose, treat, cure, or prevent any disease, including insomnia or any sleep disorder. None of this is medical advice — talk to a clinician about your situation.